Veterinary Medicines

KETABEL 100 MG/ML SOLUTION FOR INJECTION

Authorised
  • Ketamine hydrochloride
Download as PDF

Product identification

Medicine name:
KETABEL 100 MG/ML SOLUTION FOR INJECTION
Ketabel vet. 100 mg/ml stungulyf, lausn
Active substance:
  • Ketamine hydrochloride
Target species:
  • Cattle
  • Pig
  • Rat
  • Guinea pig
  • Rabbit
  • Cat
  • Sheep
  • Goat
  • Dog
  • Horse
  • Hamster
  • Mouse
Route of administration:
  • Intramuscular use
  • Intravenous use
  • Intraperitoneal use

Product details

Active substance and strength:
  • Ketamine hydrochloride
    115.34
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        1
        day
    • Pig
      • Meat and offal
        1
        day
    • Rat
    • Guinea pig
    • Rabbit
    • Cat
    • Sheep
      • Meat and offal
        1
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        1
        day
      • Milk
        0
        day
    • Dog
  • Intravenous use
    • Cattle
      • Meat and offal
        1
        day
      • Milk
        0
        day
    • Horse
      • Meat and offal
        1
        day
      • Milk
        0
        day
    • Sheep
      • Meat and offal
        1
        day
      • Milk
        0
        day
    • Goat
      • Meat and offal
        1
        day
      • Milk
        0
        day
  • Intraperitoneal use
    • Hamster
    • Rat
    • Mouse
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QN01AX03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Iceland
Available in:
  • Iceland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Bela-Pharm GmbH & Co. KG
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bela-Pharm GmbH & Co. KG
Responsible authority:
  • Icelandic Medicines Agency
Authorisation number:
  • IS/2/20/006/01
Date of authorisation status change:
Reference member state:
  • France
Procedure number:
  • FR/V/0338/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Norway
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."